Clinical trial / 2007
High dietary advanced glycation endproducts acutely impaired vascular function in type 2 diabetes.
In a randomized crossover trial of 20 inpatients with type 2 diabetes, participants consumed identical-ingredient meals prepared to contain either high (15,100 kU) or low (2,750 kU) advanced glycation endproducts. Flow-mediated dilatation decreased more after the high-AGE meal than the low-AGE meal (-36.2% vs -20.9%, P<0.001). The high-AGE meal also reduced microvascular function by 67.2% and increased serum advanced glycation endproducts, oxidative stress, and endothelial dysfunction markers.
- Study type
- Randomized crossover trial
- Who was studied
- 20 inpatients with type 2 diabetes (mean age 55.4 years)
- What was measured
- Macro- and microvascular endothelial function, oxidative stress, and serum AGE levels
THE PAPER
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Am J Clin Nutr, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.